Mylan to launch generic EpiPen at half the price of original

(Reuters) - Mylan NV said it would launch the first generic version of its allergy auto-injector EpiPen at half the price of the branded product, the drugmaker's second step in less than a week to counter a wave of criticism over the product's high price.

Mylan to launch generic EpiPen at half the price of original
Read More


Bagikan Berita Ini